Marine Bacterial Sources of Bioactive Compounds

Advances in Food and Nutrition Research

Volumn 65, Issue , 2012, Pages 389-408

  Jaiganesh, R ^a   Sampath Kumar, N S ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Actinomycetes; Antitumor agent; Bioactive compounds; Cyanobacteria; Marine bacteria

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTIVIRUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ACTINOMYCES; ANIMAL; AQUATIC SPECIES; ARTICLE; BIOSYNTHESIS; CHEMISTRY; CYANOBACTERIUM; DRUG DEVELOPMENT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; ISOLATION AND PURIFICATION; METABOLISM;

ACTINOMYCES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBIOTICS, ANTINEOPLASTIC; ANTIVIRAL AGENTS; AQUATIC ORGANISMS; CYANOBACTERIA; DRUG DISCOVERY; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS;

EID: 84857217071     PISSN: 10434526     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-416003-3.00025-1     Document Type: Article

References (99)

1. Abdel-Mageed W.M., Milne B.F., Wagner M., Schumacher M., Sandor P., Pathom-aree W., Goodfellow M., Bull A.T., Horikoshi K., Ebel R., Diederich M., Fiedler H.P., et al. Dermacozines, a new phenazine family from deep-sea Dermacocci isolated from a Mariana Trench sediment. Org. Biomol. Chem. 2010, 8:2352-2362.
2. Andrianasolo E.H., Gross H., Goeger D., Musafija-Girt M., McPhail K., Leal R.M. Isolation of swinholide A and related glycosylated derivatives from two field collections of marine cyanobacteria. Org. Lett. 2005, 7(7):1375-1378.
3. Arena A., Maugeri T.L., Pavone B., Iannello D., Gugliandolo C., Bisignano G. Antiviral and immunomodulatory effect of a novel exopolysaccharide from a marine thermotolerant Bacillus licheniformis. Int. Immunopharmacol. 2006, 6:8-13.
4. Arena A., Gugliandolo C., Stassi G., Pavone B., Iannello D., Bisignano G., Maugeri T.L. An exopolysaccharide produced by Geobacillus thermodenitrificans strain B3-72: Antiviral activity on immuno competent cells. Immunol. Lett. 2009, 123:132-137.
5. Arif J.M., Al-Hazzani A.A., Kunhi M., Al-Khodairy F. Novel marine compounds: Anticancer or genotoxic. J. Biomed. Biotechnol. 2004, 2:93-98.
6. Asolkar R.N., Maskey R.P., Helmke E., Laatsch H. Chalcomycin B, a new macrolide antibiotic from the marine isolate Streptomyces sp. B7064. J. Antibiot. 2002, 55:893-898.
7. Barchi J.J., Moore R.E., Patterson G.M.L. Acutiphycin and 20, 21-Didehydroacutiphycin, new antineoplastic agents from the Cyanophyta Oscillatoria acutissima. J. Am. Chem. Soc. 1984, 106:8193-8197.
8. Barsby T., Kelly M.T., Gagne S.M., Andersen R.J. Bogorol A produced in culture by a marine Bacillus sp. reveals a novel template for cationic peptide antibiotics. Org. Lett. 2001, 3:437-440.
9. Bhat V.B., Madyastha K.M. C-phycocyanin: A potent peroxyl radical scavenger in vivo and in vitro. Biochem. Biophys. Res. Commun. 2000, 275(1):20-25.
10. Bister B., Bischoff D., Strobele M., Riedlinger J., Reicke A., Wolter F., Bull A.T., Zahner H., Fiedler H.P., Sussmuth R.D. Abyssomicin C-A polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Angew. Chem. Int. Ed Engl. 2004, 43:2574-2576.
11. Bruntner C., Binder T., Pathom-aree W., Goodfellow M., Bull A.T., Potterat O., Puder C., Horer S., Schmid A., Bolek W. Frigocyclinone, a novel angucyclinone antibiotic produced by a Streptomyces griseus strain from Antarctica. J. Antibiot. 2005, 58:346-349.
12. Buchanan G.O., Williams P.G., Feling R.H., Kauffman C.A., Jensen P.R., Fenical W. Sporolides A and B: Structurally unprecedented halogenated macrolides from the marine actinomycete Salinispora tropica. Org. Lett. 2005, 7:2731-2734.
13. Burja A.M., Banaigs B., Abou-Mansour E., Burgess J.G., Wright P.C. Marine cyanobacteria-A prolific source of natural products. Tetrahedron 2001, 57:9347-9377.
14. Cardellina J.H., Kirkup M.P., Moore R.E., Mynderse J.S., Seff K., Simmons C.J. Hyellazole and chlorohyellazole, two novel carbozoles from the blue-green algae Hyella caeslitosa born. Tetrahedron Lett. 1979, 51:4915-4921.
15. Charan R.D., Schlingmann G., Janso J., Bernan V., Feng X., Carter G.T. Diazepi-nomicin, a new antimicrobial alkaloid from a marine Micromonospora sp. J. Nat. Prod. 2004, 67:1431-1433.
16. Colwell R.R. Microbial biodiversity and biotechnology. Biodiversity II: Understanding and Protecting Our Biological Resources 1997, 279-287. Joseph Henry Press, Washington, DC. M.E. Reaka-Kudla, E. Wilson (Eds.).
17. Desjardine K., Pereira A., Wright H., Matainaho T., Kelly M., Andersen R.J. Tauramamide, a lipopeptide antibiotic produced in culture by Brevibacillus laterosporus isolated from a marine habitat: Structure elucidation and synthesis. J. Nat. Prod. 2007, 70:1850-1853.
18. El-Gendy M.M., Hawas U.W., Jaspars M. Novel bioactive metabolites from a marine derived bacterium Nocardia sp. ALAA 2000. J. Antibiot. 2008, 61:379-386.
19. El-Gendy M.M., Shaaban M., Shaaban K.A., El-Bondkly A.M., Laatsch H. Essramycin: A first triazolopyrimidine antibiotic isolated from nature. J. Antibiot. 2008, 61:149-157.
20. Engelhardt K., Degnes K.F., Kemmler M., Bredholt H., Fjaervik E., Klinkenberg G., Sletta H., Ellingsen T.E., Zotchev S.B. Production of a new thiopeptide antibiotic, TP-1161, by a marine Nocardiopsis species. Appl. Environ. Microbiol. 2010, 76:4969-4976.
21. Feling R.H., Buchanan G.O., Mincer T.J., Kauffman C.A., Jensen P.R., Fenical W. Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew. Chem. Int. Ed Engl. 2003, 42:355-357.
22. Fenical W. Marine Products, Discovery and Commercialisation Available at:. http://www.senate.gov/Senate404.htm.
23. Fiedler H.P., Bruntner C., Riedlinger J., Bull A.T., Knutsen G., Goodfellow M., Jones A., Maldonado L., Pathom-aree W., Beil W., Schneider K., Keller S., et al. Proximicin A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora. J. Antibiot. 2008, 61:158-163.
24. Fischbach M.A., Walsh C.T. Antibiotics for emerging pathogens. Science 2009, 325:1089-1093.
25. Gao X., Hall D.G. Catalytic asymmetric synthesis of a potent thiolmarinol antibiotic. J. Am. Chem. Soc. 2005, 127(6):1628-1629.
26. Gbankoto A., Vigo J., Dramane K., Banaigs B., Aina E., Salmon J.M. Cytotoxic effect of Laxaphycins A and B on human lymphoblastic cells (CCRF-CEM) using digitised videomicrofluorometry. In Vivo 2005, 19(3):577-582.
27. Gochfeld D.J., El Sayed K.A., Yousaf M., Hu J.F., Bartyzel P., Dunbar D.C., Wilkins S.P., Zjawiony J.K., Schinazi R.F., Schlueter Wirtz S., Tharnish P.M., Hamann M.T. Marine natural products as lead anti-HIV agents. Mini Rev. Med. Chem. 2003, 3:401-424.
28. Gourdeau H., McAlpine J.B., Ranger M., Simard B., Berger F., Beaudry F., Farnet C.M., Falardeau P. Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand. Cancer Chemother. Pharmacol. 2008, 61:911-921.
29. Gustafson K.R., Roman M., Fenical W. The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium. J. Am. Chem. Soc. 1989, 111:7519-7524.
30. Haefner B. Drugs from the deep: Marine natural products as drug candidates. Drug Discov. Today 2003, 8:536-544.
31. Han B., Gross H., Goeger D.E., Mooberry S.L., Gerwick W.H. Aurilides B and C, cancer cell toxins from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2006, 69(4):572-575.
32. Harrigan G.G., Yoshida W.Y., Moore R.E., Nagle D.G., Park P.U., Biggs J., Paul V.J., Mooberry S.L., Corbett T.H., Valeriote F.A. Isolation, structure determination, and biological activity of dolastatin-12 and lyngbyastatin-I from Lyngbya majuscula Schizothrix calcicola cyanobacterial assemblages. J. Nat. Prod. 1998, 61(10):1221-1225.
33. Harrigan G.G., Luesch H., Yoshida W.Y., Moore R.E., Nagle D.G., Paul V.J., Mooberry S.L., Corbett T.H., Valeriote F.A. Symplostatin 1. A dolastatin 10 analogue from marine cyanobacterium Symploca hydnoides. J. Nat. Prod. 1998, 61:1075-1077.
34. Hawas U.W., Shaaban M., Shaaban K.A., Speitling M., Maier A., Kelter G., Fiebig H.H., Meiners M., Helmke E., Laatsch H. Mansouramycins A-D, cytotoxic isoquinolinequinones from a marine Streptomycete. J. Nat. Prod. 2009, 72:2120-2124.
35. Hohmann C., Schneider K., Bruntner C., Brown R., Jones A.L., Goodfellow M., Krämer M., Imhoff J.F., Nicholson G., Fiedler H.P., Süssmuth R.D. Albidopyrone, a new alpha-pyrone-containing metabolite from marine-derived Streptomyces sp. NTK 227. J. Antibiot. 2009, 62:75-79.
36. Hughes C.C., Prieto-Davo A., Jensen P.R., Fenical W. The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. Org. Lett. 2008, 10(4):629-631.
37. Ireland C.M., Copp B.R., Foster M.D., McDonald L.A., Radisky D.C., Swersey J.C. Biomedical potential of marine natural products. Pharmaceutical and Bioactive Natural Products 1993, Vol. 1:1-43. Plenum Press, New York. D.H. Attaway, O.R. Zaborsky (Eds.).
38. Isnansetyo A., Kamei Y. MC21-A, a bactericidal antibiotic produced by a new marine bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30 (T), against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2003, 47:480-488.
39. Issa A.A. Antibiotic production by the cyanobacteria Oscillatoria angustissima and Calothrix parietina. Environ. Toxicol. Pharmacol. 1999, 8:33-37.
40. Jang J.H., Kanoh K., Adachi K., Shizuri Y. New dihydrobenzofuran derivative, awajanoran, from marine-derived Acremonium sp. AWA16-1. J. Antibiot. 2006, 59(7):428-431.
41. Jensen P.R., Mincer T.J., Williams P.G., Fenical W. Marine Actinomycete diversity and natural product discovery. Antonie Van Leeuwenhoek 2005, 87:43-48.
42. Kamata K., Okamoto S., Oka S. Cycloprodigiosin hydrochloride suppresses tumor necrosis factor (TNF) alpha-induced transcriptional activation by NF-kappaB. FEBS Lett. 2001, 507:74-80.
43. Kanoh K., Matsuo Y., Adachi K., Imagawa H., Nishizawa M., Shizuri Y. Mechercharmycins A and B, cytotoxic substances from marine-derived Thermoactinomyces sp. YM3-251. J. Antibiot. 2005, 58:289-292.
44. Knubel G., Larsen L.K., Moore R.E., Levine I.A., Patterson G.M. Cytotoxic and antiviral indolocarbozoles from a blur green alga belonging to the nostocaceae. J. Antibiot. 1990, 43:1236-1239.
45. Koehn F.E., Longley R.E., Reed J.K. Microcolins A and B, new immunosuppressive peptide from the blue-green alga Lyngbya majuscule. J. Nat. Prod. 1992, 55:613-619.
46. Lane A.L., Moore B.S. A sea of biosynthesis: Marine natural products meet the molecular age. Nat. Prod. Rep. 2011, 28:411-428.
47. Li F., Maskey R.P., Qin S., Sattler I., Fiebig H.H., Maier A., Zeeck A., Laatsch H. Chinikomycins A and B: Isolation, structure elucidation, and biological activity of novel antibiotics from a marine Streptomyces sp. Isolate M045. J. Nat. Prod. 2005, 68:349-353.
48. Liu X., Ashforth E., Ren B., Song F., Dai H., Liu M., Wang J., Xie Q., Zhang L. Bioprospecting microbial natural product libraries from the marine environment for drug discovery. J. Antibiot. 2010, 63:415-422.
49. Lu K., Dempsey J., Schultz R.M. Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cells. Cancer Chemother. Pharmacol. 2001, 47:170-178.
50. Macherla V.R., Liu J., Bellows C., Teisan S., Lam K.S., Potts B.C.M. Glaciapyrroles A, B and C, pyrrolosesquiterpenes from a Streptomyces sp. isolated from an Alaskan marine sediment. J. Nat. Prod. 2005, 68:780-783.
51. Macherla V.R., Mitchell S.S., Manam R.R., Reed K.A., Chao T.H., Nicholson B. Structure-activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitor. J. Med. Chem. 2005, 48(11):3684-3687.
52. Macherla V.R., Liu J., Sunga M., White D.J., Grodberg J., Teisan S., Lam K.S., Potts B.C. Lipoxazolidinones A, B, and C: Antibacterial 4-oxazolidinones from a marine actinomycete isolated from a Guam marine sediment. J. Nat. Prod. 2007, 70:1454-1457.
53. Magarvey N.A., Keller J.M., Bernan V., Dworkin M., Sherman D.H. Isolation and characterization of novel marine-derived actinomycete taxa rich in bioactive metabolites. Appl. Environ. Microbiol. 2004, 70(12):7520-7529.
54. Malakoff D. Extinction on the high seas. Science 1997, 277:486-488.
55. Maldonado L.A., Fenical W., Jensen P.R., Kauffman C.A., Mincer T.J., Ward A.C., Bull A.T., Goodfellow M. Salinispora arenicola gen. nov., sp. nov. and Salinispora tropica sp. nov., obligate marine actinomycetes belonging to the family Micromonosporaceae. Int. J. Syst. Evol. Microbiol. 2005, 55:1759-1766.
56. Maskey R.P., Helmke E., Laatsch H. Himalomycin A and B: Isolation and structure elucidation of new fridamycin type antibiotics from a marine Streptomyces isolate. J. Antibiot. 2003, 56:942-949.
57. Maskey R.P., Helmke E., Kayser O., Fiebig H.H., Maier A., Busche A., Laatsch H. Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry. J. Antibiot. 2004, 57:771-779.
58. McArthur K.A., Mitchell S.S., Tsueng G., Rheingold A., White D.J., Grodberg J., Lam K.S., Potts B.C. Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete. J. Nat. Prod. 2008, 71:1732-1737.
59. Mishima T., Murata J., Toyoshima M., Fujii H., Nakajima M., Hayashi T., Kato T., Saiki I. Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green algae, Spirulina platensis. Clin. Exp. Metastasis 1998, 16(6):541-550.
60. Mitchell S.S., Nicholson B., Teisan S., Lam K.S., Potts B.C. Aureoverticillactam, a novel 22-atom macrocyclic lactam from the marine actinomycete Streptomyces aureoverticillatus. J. Nat. Prod. 2004, 67:1400-1402.
61. Moore R.E. Toxins, anticancer agents, and tumor promoters from marine prokaryotes. Pure Appl. Chem. 1982, 54:1919-1934.
62. Moore R.E., Blackman A.J., Cheuk C.E., Mynderse J.S., Matsumoto G.K., Clardy J., Woodard R.W., Craig J.C. Absolute stereochemistries of the aplysiatoxins and oscillatoxin A. J. Org. Chem. 1984, 49:2484-2489.
63. Murakami N., Morimoto T., Imamura H., Ueda T., Nagai S., Sakakibara J., Yamada N. Studies on glycolipids. III. Glyceroclycolipids from an axenically cultured cyanobacterium, Phormidium tenue. Chem. Pharm. Bull. 1991, 39(9):2277-2281.
64. Mynderse J.S., Moore R.E., Kashiwagi M., Norton T.R. Antileukemia activity in the Oscillatoriaceae: Isolation of debromoaplysiatoxin from Lyngbya. Science 1977, 196:538-540.
65. Nakao Y., Takada K., Matsunaga S., Fusetani N. Calyceramides A-C: Neuraminidase inhibitory sulfated ceramides from the marine sponge Discodermia calyx. Tetrahedron 2001, 57:3013-3017.
66. Newman D.J., Cragg G.M. The discovery of anticancer drugs from natural sources. Natural Products: Drug Discovery and Therapeutics Medicines 2005, 275-294. Humana Press, New York. L. Zhang, A. Demain (Eds.).
67. Norton R.S., Wells R.J. A series of chiral polybrominated biindoles from the marine blue-green alga Rivularia firma. Application of carbon-13 NMR spin-lattice relaxation data and carbon-13-proton coupling constants to structure elucidation. J. Am. Chem. Soc. 1982, 104:3628-3635.
68. Oku N., Adachi K., Matsuda S., Kasai H., Takatsuki A., Shizuri Y. Ariakemicins A and B, novel polyketide-peptide antibiotics from a marine gliding bacterium of the genus Rapidithrix. Org. Lett. 2008, 10:2481-2484.
69. Olaizola M. Commercial development of microalgal biotechnology: From the test tube to the market place. Biomol. Eng. 2003, 20:459-466.
70. Parkes R.J., Cragg B.A., Bale S.J., Getliff J.M., Goodman K., Rochelle P.A., Fry J.C., Weightman A.J., Harvey S.M. Deep bacterial biosphere in Pacific Ocean sediments. Nature 1994, 371:410-413.
71. Penn K., Jenkins C., Nett M., Udwary D.W., Gontang E.A., McGlinchey R.P., Foster B., Lapidus A., Podell S., Allen E.E., Moore B.S., Jensen P.R. Genomic islands link secondary metabolism to functional adaptation in marine Actinobacteria. ISME J. 2009, 3:1193-1203.
72. Perez Baz J., Cañedo L.M., Fernández Puentes J.L., Silva Elipe M.V. Thiocoraline, a novel depsipeptide with antitumor activity produced by a marine Micromonospora. II. Physico-chemical properties and structure determination. J. Antibiot. 1997, 50:738-741.
73. Piel J., Hertweck C., Shipley P.R., Hunt D.M., Newman M.S., Moore B.S. Cloning, sequencing and analysis of the enterocin biosynthesis gene cluster from the marine isolate 'Streptomyces maritimus': Evidence for the derailment of an aromatic polyketide synthase. Chem. Biol. 2000, 7:943-955.
74. Prinsep M.R., Moore R.E., Levine I.A., Patterson G.M.L. Westiellamide, a bistratamide-related cyclic peptide from the blue-green alga Westiellopsis prolifica. J. Nat. Prod. 1992, 55(1):140-142.
75. Rath J.P., Kinast S., Maier M.E. Synthesis of the full functionalized core structure of the antibiotic abyssomicin C. Org. Lett. 2005, 7:3089-3092.
76. Raveh A., Carmeli S. Antimicrobial ambiguines from the cyanobacterium Fischerella sp. collected in Israel. J. Nat. Prod. 2007, 70:196-201.
77. Reddy C.M., Bhat V.B., Kiranmai G., Reddy M.N., Reddanna P., Madyastha K.M. Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis. Biochem. Biophys. Res. Commun. 2007, 277(3):599-603.
78. Reshef V., Mizrachi E., Maretzki T., Silberstein C., Loya S., Hizi A., Carmeli S. New acylated sulfoglycolipids and digalactolipids and related known glycolipids from cyanobacteria with a potential to inhibit the reverse transcriptase of HIV-1. J. Nat. Prod. 1997, 60:1251-1260.
79. Riedlinger J., Reicke A., Zahner H., Krismer B., Bull A.T., Maldonado L.A., Ward A.C., Goodfellow M., Bister B., Bischoff D. Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J. Antibiot. (Tokyo) 2004, 57:271-279.
80. Rinker K.D., Kelly R.M. Effect of carbon and nitrogen sources on growth dynamics and exopolysaccharide production for the Hyperthermophilic archaeon, Thermococcus litoralis and bacterium Thermotoga maritima. Biotechnol. Bioeng. 2000, 69:537-547.
81. Rondon M.R., Ballering K.S., Thomas M.G. Identification and analysis of a siderophore biosynthetic gene cluster from Agrobacterium tumefaciens C58. Microbiology 2004, 150(11):3857-3866.
82. Sabdono A., Radjasa O.K. Antifouling activity of bacteria associated with soft coral Sarcophyton sp. against marine biofilm-forming bacteria. J. Coast. Dev. 2006, 10(1):55-62.
83. Schumacher R.W., Talmage S.C., Miller S.A., Sarris K.E., Davidson B.S., Goldberg A. Isolation and structure determination of an antimicrobial ester from a marine derived bacterium. J. Nat. Prod. 2003, 66:1291-1293.
84. Schwartz J., Shklar G. Regression of experimental hamster cancer by beta carotene and algae extracts. J. Oral Maxillofac. Surg. 1987, 45:510-515.
85. Simmons T.L., McPhail K.L., Ortega-Barria E., Mooberry S.L., Gerwick W.H. Belamide A, a new antimitotic tetrapeptide from a Panamanian marine cyanobacterium. Tetrahedron Lett. 2006, 47(20):3387-3390.
86. Singh M.P., Kong F., Janso J.E., Arias D.A., Saurez P.A., Barnas V.S. Novel-α-pyrones by a marine Pseudomonas sp. F92S91: Taxonomy and biological activities. J. Antibiot. 2003, 56(12):1033-1044.
87. Soria-Mercado I.E., Prieto-Davo A., Jensen P.R., Fenical W. Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J. Nat. Prod. 2005, 68(6):904-910.
88. Stratmann K., Belli J., Jensen C.M., Moore R.E., Patterson G.M. Aulosirazole, a novel solid tumor selective cytotoxin from the blue-green alga Aulosire fertilissima. J. Org. Chem. 1994, 59(21):6279-6281.
89. Tokuda H., Nishino H., Shirahashi H., Murakami N., Nagatsu A., Sakakibara J. Inhibition of 12-O-tetradecanoylphorbol-13-acetate promoted mouse skin papilloma by digalactosyl diacylglycerols from the fresh water cyanobacterium Phormidium tenue. Cancer Lett. 1996, 104(1):91-95.
90. Tuin A.W., Grotenbreg G.M., Spalburg E., de Neeling A.J., Mars-Groenendijk R.H., Vander Marel G.A. Structural and biological evaluation of some loloatin C analogues. Bioorg. Med. Chem. 2009, 17(17):6233-6240.
91. Tziveleka L.A., Vagias C., Roussis V. Natural products with anti HIV activity from marine organism. Curr. Top. Med. Chem. 2003, 3(13):1512-1535.
92. Williams P.G., Yoshida W.Y., Moore R.E., Paul V.J. Tasipeptins A and B: New cytotoxic depsipeptides from the marine cyanobacterium Symploca sp. J. Nat. Prod. 2003, 66:620-624.
93. Williams P.G., Yoshida W.Y., Quon M.K., Moore R.E., Paul V.J. The structure of Palau'amide, a potent cytotoxin from a species of the marine cyanobacterium Lyngbya. J. Nat. Prod. 2003, 66:1545-1549.
94. Williams P.G., Yoshida W.Y., Moore R.E., Paul V.J. The isolation and structure elucidation of Tasiamide B, a 4-amino-3-hydroxy-5-phenylpentanoic acid containing peptide from the marine Cyanobacterium Symploca sp. J. Nat. Prod. 2003, 66:1006-1009.
95. Williams P.G., Yoshida W.Y., Moore R.E., Paul V.J. Micromide and guamamide: Cytotoxic alkaloids from a species of the marine cyanobacterium Symploca. J. Nat. Prod. 2004, 67:49-53.
96. Winston J.E. The systematists' perspective. Biomedical Importance of Marine Organisms 1988, 1-6. California Academy of Sciences, San Francisco, CA. D.G. Fautin (Ed.).
97. Wu S.J., Fotso S., Li F., Qin S., Kelter G., Fiebig H.H. N-carboxamido-staurosporine and selina-4(14), 7(11)-diene-8, 9-diol, new metabolites from a marine Streptomyces sp. J. Antibiot. (Tokyo) 2006, 59(6):331-337.
98. Yang H., Lee E., Kim H. Spirulina platensis inhibits anaphylactic reaction. Life Sci. 1997, 61(13):1237-1244.
99. Zhang H.L., Hua H.M., Pei Y.H., Yao X.S. Three new cytotoxic cyclic acylpeptides from marine Bacillus sp. Chem. Pharm. Bull. (Tokyo) 2004, 52:1029-1030.